Tuesday, July 30, 2024

🌎 3M Upgraded, Novavax Downgraded, Sprouts Farmers Market Upgraded and more...

Ratings changes for CrowdStrike, Symbotic, Adaptimmune Therapeutics, Encore Wire, Novavax, Sprouts Farmers Market, Amkor Technology and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Unsubscribe.
MarketBeat Daily Ratings
July 30th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
This Semiconductor Stock Is ON Track for a New High
American consumers feeling more confident in July as expectations of future improve
Kiss of death for Democrats (Porter & Company)
Why SoFi Stock is an Unmissable Growth Opportunity
U.S. job openings fall slightly to 8.2 million as high interest rates continue to cool labor market
Has Micron's Stock Drop Turned Into A Screaming Buy?
Ethiopia's currency dives by 30% as IMF-backed reforms to stabilize the economy take effect
Musk's new company could top a trillion? (Paradigm Press)
Should You Invest in Bonds? Here's What to Know
China's top leaders vow to support consumers and improve confidence in its slowing economy
Why This Manufacturer is Committing to a Massive Buyback Program
Europe's growth lags US again, as Germany remains the eurozone's economic problem child
Top Stock Picks Amid Tech Market Meltdown
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Affirm (NASDAQ:AFRM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $36.00 price target on the stock. This represents a 26.4% upside from the current price of $28.47.
  • AON (NYSE:AON) was upgraded by analysts at Keefe, Bruyette & Woods from an "underperform" rating to an "outperform" rating. They now have a $380.00 price target on the stock, up previously from $313.00. This represents a 16.1% upside from the current price of $327.22.
  • ASML (NASDAQ:ASML) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.The current price is $888.45.
  • BrightView (NYSE:BV) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $17.00 price target on the stock, up previously from $13.00. This represents a 21.7% upside from the current price of $13.97.
  • Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $47.00 price target on the stock. This represents a 24.5% upside from the current price of $37.74.
  • LPL Financial (NASDAQ:LPLA) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $268.00 price target on the stock. This represents a 21.2% upside from the current price of $221.09.
  • 3M (NYSE:MMM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $145.00 price target on the stock. This represents a 16.3% upside from the current price of $124.66.
  • RTX (NYSE:RTX) was upgraded by analysts at Alembic Global Advisors from a "neutral" rating to an "overweight" rating. They now have a $134.00 price target on the stock. This represents a 15.7% upside from the current price of $115.80.
  • Sprouts Farmers Market (NASDAQ:SFM) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $90.00 price target on the stock, up previously from $62.00. This represents a 8.9% downside from the current price of $98.76.
  • Sprouts Farmers Market (NASDAQ:SFM) was upgraded by analysts at BMO Capital Markets from an "underperform" rating to a "market perform" rating. They now have a $102.00 price target on the stock, up previously from $40.00. This represents a 3.3% upside from the current price of $98.76.
  • Varonis Systems (NASDAQ:VRNS) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $60.00 price target on the stock, up previously from $52.00. This represents a 10.2% upside from the current price of $54.44.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Abbott Laboratories (NYSE:ABT) was downgraded by analysts at Edward Jones from a "buy" rating to a "hold" rating.The current price is $104.28.
  • Bank of Montreal (NYSE:BMO) (TSE:BMO) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.The current price is $83.98.
  • Cognition Therapeutics (NASDAQ:CGTX) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.The current price is $1.14.
  • Criteo (NASDAQ:CRTO) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $43.70.
  • Centuri (NYSE:CTRI) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $17.00 price target on the stock, down previously from $30.00. This represents a 7.9% upside from the current price of $15.76.
  • Flushing Financial (NASDAQ:FFIC) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $16.50 price target on the stock, up previously from $15.00. This represents a 10.9% upside from the current price of $14.88.
  • Gentex (NASDAQ:GNTX) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $34.00 price target on the stock. This represents a 8.1% upside from the current price of $31.45.
  • Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $16.00 price target on the stock, down previously from $17.00. This represents a 9.8% downside from the current price of $17.73.
  • Integra LifeSciences (NASDAQ:IART) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $23.00 price target on the stock, down previously from $30.00. This represents a 7.4% downside from the current price of $24.85.
  • Integra LifeSciences (NASDAQ:IART) was downgraded by analysts at BTIG Research from a "neutral" rating to a "sell" rating. They now have a $22.00 price target on the stock. This represents a 11.5% downside from the current price of $24.85.
  • Lattice Semiconductor (NASDAQ:LSCC) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $47.00 price target on the stock, down previously from $83.00. This represents a 7.2% downside from the current price of $50.64.
  • Merchants Bancorp (NASDAQ:MBIN) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $58.00 price target on the stock, up previously from $55.00. This represents a 29.2% upside from the current price of $44.89.
  • Novavax (NASDAQ:NVAX) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $8.00 price target on the stock. This represents a 37.4% downside from the current price of $12.78.
  • Sage Therapeutics (NASDAQ:SAGE) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $10.00 price target on the stock, down previously from $16.00. This represents a 6.8% downside from the current price of $10.73.
  • Shore Bancshares (NASDAQ:SHBI) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating.The current price is $14.41.
  • Silicom (NASDAQ:SILC) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $13.12.
  • Frontier Group (NASDAQ:ULCC) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.The current price is $4.09.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Adaptimmune Therapeutics (NASDAQ:ADAP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $4.00 price target on the stock. This represents a 172.1% upside from the current price of $1.47.
  • Corbus Pharmaceuticals (NASDAQ:CRBP) is now covered by analysts at Wedbush. They set an "outperform" rating and a $85.00 price target on the stock. This represents a 43.1% upside from the current price of $59.41.
  • Gryphon Digital Mining (NASDAQ:GRYP) is now covered by analysts at HC Wainwright. They set a "neutral" rating on the stock.The current price is $0.94.
  • Ligand Pharmaceuticals (NASDAQ:LGND) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $130.00 price target on the stock. This represents a 18.7% upside from the current price of $109.56.
  • Movano (NASDAQ:MOVE) is now covered by analysts at Benchmark Co.. They set a "speculative buy" rating and a $2.00 price target on the stock. This represents a 404.0% upside from the current price of $0.40.
  • Whirlpool (NYSE:WHR) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $88.00 price target on the stock. This represents a 11.6% downside from the current price of $99.52.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: DOLLAR RECALL ON THE AGENDA
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

How Our Biggest Breakthrough Ever Doubled the Market’s Return

Going back to the horse and buggy…   December 25, 2024 How Our Biggest Breakthrough Ever Doubled the Market’s Return...